Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 2/20 | 0.60 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.60 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.60 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.60 |
| ▸ | SELP | P16109 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | FAAH | O00519 | 3/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | CNR1 | P21554 | 1/20 | 0.51 |
| ▸ | CNR2 | P34972 | 1/20 | 0.51 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.50 |
| ▸ | NR5A2 | O00482 | 1/20 | 0.50 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.50 |
| ▸ | DGKA | P23743 | 1/20 | 0.50 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.50 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27216392 | 0.93 | MEN1 (0.52) | PRKCAPRKCEPRKCQPRKCDSELP | |
| SCHEMBL27238682 | 0.93 | MEN1 (0.52) | PRKCAPRKCEPRKCQPRKCDSELP | |
| SCHEMBL27238684 | 0.88 | FAAH (0.61) | SELPFAAHLPAR1DGKAENPP2 | |
| SCHEMBL18072622 | 0.88 | PRKCA (0.64) | PRKCAPRKCEPRKCQPRKCDSELP | |
| SCHEMBL7755332 | 0.87 | PRKCA (0.59) | PRKCAPRKCEPRKCQPRKCDSELP | |
| SCHEMBL7755337 | 0.87 | PRKCA (0.59) | PRKCAPRKCEPRKCQPRKCDSELP | |
| SCHEMBL24688413 | 0.85 | FAAH (0.51) | PRKCAPRKCEPRKCQPRKCDALDH1A1 | |
| SCHEMBL12464578 | 0.85 | PRKCA (0.80) | PRKCAPRKCEPRKCQPRKCDSELP | |
| SCHEMBL1898251 | 0.85 | PRKCA (0.80) | PRKCAPRKCEPRKCQPRKCDSELP | |
| SCHEMBL22078371 | 0.85 | PRKCA (0.80) | PRKCAPRKCEPRKCQPRKCDSELP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240189235-A1 | CATIONIC LIPIDS AND USES THEREOF | MELLO BIOTECH TAIWAN CO., LTD. (TW) | 2024-06-13 | — | — | US | disclosed |
| EP-4368609-A1 | CATIONIC LIPIDS AND USES THEREOF | Mello Biotech Taiwan Co., Ltd. (TW) | 2024-05-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240189235-A1 | CATIONIC LIPIDS AND USES THEREOF | LIPA, APOB, NPC1 | PRKCA 4100/4885PRKCE 4180/4885PRKCQ 4044/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.